P
32,100
-3.31%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩365.56bn
FY2016FY2025
Net income
−₩8.41bn
FY2016FY2025
Free cash flow
₩19.46bn
FY2016FY2025
Shareholders' equity
₩799.10bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩365.56bn | ₩342.38bn | ₩333.48bn | ₩385.68bn | ₩403.79bn | ₩488.77bn | ₩535.94bn | ₩404.76bn | ₩52.38bn | ₩92.73bn |
| Research and development | — | — | — | — | — | — | — | — | ₩24.4m | ₩24.4m |
| Operating income | −₩14.81bn | ₩3.76bn | −₩16.39bn | ₩16.06bn | ₩42.83bn | ₩157.29bn | ₩148.91bn | ₩168.11bn | ₩21.66bn | ₩59.57bn |
| Net income | −₩8.41bn | ₩60.34bn | ₩15.21bn | −₩43.00bn | ₩59.37bn | ₩100.85bn | ₩157.65bn | ₩146.45bn | ₩14.73bn | ₩50.86bn |
| Diluted earnings per share | -137.01 | 982.48 | 247.58 | -701.73 | 970.77 | 1,675.82 | 2,594.70 | 11,878.38 | 262.63 | 1,080.14 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩1.15trn | ₩1.14trn | ₩1.21trn | ₩1.22trn | ₩1.36trn | ₩897.19bn | ₩867.39bn | ₩712.53bn | ₩296.58bn | ₩101.69bn |
| Cash and short-term investments | — | ₩365.76bn | ₩507.62bn | ₩483.10bn | ₩646.89bn | ₩419.60bn | ₩370.98bn | ₩286.02bn | ₩261.57bn | ₩69.18bn |
| Total liabilities | ₩350.00bn | ₩336.85bn | ₩487.89bn | ₩523.25bn | ₩637.60bn | ₩260.28bn | ₩278.37bn | ₩304.50bn | ₩21.38bn | ₩23.14bn |
| Debt | ₩56.20bn | ₩102.43bn | ₩247.72bn | ₩329.05bn | ₩344.29bn | ₩123.04bn | ₩150.15bn | ₩176.29bn | — | ₩1.05bn |
| Shareholders' equity | ₩799.10bn | ₩805.97bn | ₩724.99bn | ₩699.30bn | ₩719.00bn | ₩636.91bn | ₩589.02bn | ₩408.03bn | ₩275.20bn | ₩78.55bn |
| Shares outstanding | 61m | 61m | 61m | 61m | 61m | 60m | 61m | 12m | 56m | 47m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩23.93bn | −₩5.39bn | ₩32.42bn | ₩47.55bn | ₩64.44bn | ₩157.43bn | ₩168.36bn | ₩159.28bn | ₩59.41bn | ₩46.58bn |
| Capital spending | −₩4.47bn | −₩3.60bn | −₩9.28bn | −₩93.95bn | −₩47.40bn | −₩26.66bn | −₩36.95bn | −₩10.73bn | −₩5.87bn | −₩3.20bn |
| Free cash flow | ₩19.46bn | −₩8.99bn | ₩23.13bn | −₩46.39bn | ₩17.04bn | ₩130.78bn | ₩131.40bn | ₩148.54bn | ₩53.54bn | ₩43.37bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩192.61bn | ₩328.50bn | ₩95.50bn | ₩106.82bn | ₩55.38bn | ₩83.69bn | ₩95.73bn | ₩79.45bn |
| Operating income | ₩67.63bn | ₩212.10bn | −₩8.41bn | ₩10.62bn | ₩903.1m | −₩5.24bn | ₩2.19bn | ₩1.41bn |
| Net income | ₩99.54bn | ₩157.97bn | −₩15.21bn | ₩28.99bn | −₩22.70bn | ₩499.3m | ₩46.22bn | −₩7.81bn |
| Diluted earnings per share | 1,620.08 | 2,570.99 | -247.53 | 472.08 | -369.59 | 8.13 | 752.54 | -127.15 |
| Cash from operations | ₩247.83bn | −₩9.29bn | ₩11.60bn | ₩13.93bn | −₩9.61bn | ₩8.01bn | −₩7.45bn | −₩4.68bn |
| Capital spending | −₩1.07bn | −₩402.0m | −₩672.0m | −₩708.0m | −₩2.10bn | −₩988.0m | −₩1.75bn | −₩575.0m |
| Free cash flow | ₩246.75bn | −₩9.69bn | ₩10.93bn | ₩13.23bn | −₩11.70bn | ₩7.02bn | −₩9.20bn | −₩5.26bn |
| Total assets | ₩1.28trn | ₩1.41trn | ₩1.15trn | ₩1.13trn | ₩1.09trn | ₩1.14trn | ₩1.14trn | ₩1.07trn |
| Cash and short-term investments | — | — | — | — | — | ₩369.23bn | ₩365.76bn | ₩365.07bn |
| Debt | ₩71.20bn | ₩71.20bn | ₩56.20bn | ₩56.20bn | ₩11.20bn | ₩96.36bn | ₩96.96bn | ₩81.87bn |
| Shareholders' equity | ₩1.05trn | ₩961.74bn | ₩799.10bn | ₩809.24bn | ₩776.57bn | ₩807.72bn | ₩805.97bn | ₩745.71bn |
Financial ratios
Data as of 26 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -4.1% | 1.1% | -4.9% | 4.2% | 10.6% | 32.2% | — | — | — |
| Net margin | -2.3% | 17.6% | 4.6% | -11.1% | 14.7% | 20.6% | — | — | — |
| Return on equity | -1.1% | 7.5% | 2.1% | -6.1% | 8.3% | 15.8% | — | — | — |
| Return on assets | -0.7% | 5.3% | 1.3% | -3.5% | 4.4% | 11.2% | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | 42.5% | — | — |
| Revenue growth | 6.8% | 2.7% | -13.5% | -4.5% | -17.4% | -8.8% | — | — | — |
| Earnings growth | -113.9% | 296.8% | -135.4% | -172.4% | -41.1% | -36.0% | — | — | — |
| Current ratio | 3.28x | 3.40x | 1.84x | 2.36x | 2.63x | 2.65x | — | — | — |
| Debt to equity | 0.07x | 0.10x | 0.10x | 0.33x | 0.45x | 0.03x | — | — | — |
| Equity ratio | 69.5% | 70.5% | 59.8% | 57.2% | 53.0% | 71.0% | — | — | — |
| Interest coverage | -3.86x | 1.12x | -2.51x | 2.16x | 49.50x | 152.62x | — | — | — |
| R&D as a share of sales | — | — | — | — | — | — | — | 0.0% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -1.8% | -5.6% | 26.9% |
| Net income | -41.9% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -1.6% | -0.8% | 8.1% | 17.9% |
| Net margin | 7.3% | 1.7% | 7.9% | 16.8% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -273.0 | 28.2 | 156.5 | -59.8 | 142.5 | 31.1 | 14.3 | 3.5 | 188.6 |
| Price to sales | 6.3 | 5.0 | 7.1 | 6.7 | 20.9 | 6.4 | 4.2 | 1.3 | 53.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 5-for-1 split · 16 Apr 2021
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.